BioCentury
ARTICLE | Company News

Syrrx acquires Onyx small molecule assets

November 6, 2001 8:00 AM UTC

Syrrx (San Diego, Calif.) acquired the assets of ONXX's small molecules discovery program, including certain drug targets and related reagents and assays, compound libraries, and licenses to certain t...